Acrivon Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Acrivon Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2021 to Q2 2024.
  • Acrivon Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 31M shares, a 40.3% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 31M +8.9M +40.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 22.6M +717K +3.27% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 22.5M +602K +2.75% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 22.1M +20.3M +1132% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 22.1M Jun 30, 2023 10-Q 2023-08-11
Q1 2023 21.9M Mar 31, 2023 10-Q 2023-05-09
Q4 2022 21.9M +20.2M +1139% Dec 31, 2022 10-K 2024-03-28
Q3 2022 1.79M Sep 30, 2022 10-Q 2022-12-15
Q4 2021 1.77M Dec 31, 2021 10-K 2023-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.